AMRN
"Amarin announced that Vascepa capsules...and will be supported with a national commercial launch on January 28" Empiezan las ventas, a ver q tal
----http://finance.yahoo.com/news/amarin-announces-market-introduction-vascepa-123738199.html
ARNA
Arena Falters on Belviq EU Approval
http://finance.yahoo.com/news/arena-falters-belviq-eu-approval-230849432.html;_ylt=AvF.buFHt5bFeo_uoFt58vCiuYdG;_ylu=X3oDMTIxbzQ4OG80BG1pdANXaWRlIFF1b3RlcyBNb2R1bGUEcG9zAzI3BHNlYwNNZWRpYVJlY2VudFF1b3Rlc1BvcnRmb2xpb3NXaWRl;_ylg=X3oDMTFpNzk0NjhtBGludGwDdXMEbGFuZwNlbi11cwRwc3RhaWQDBHBzdGNhdANob21lBHB0A3NlY3Rpb25z;_ylv=3
no, ni idea sobre CLSN y ANAC
Amarin Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results
http://finance.yahoo.com/news/amarin-announces-first-notification-u-162811200.html
Sobre AMRN
http://www.redacre.com/insights/2013/jan/23/amarin-anchor-patent-allowed-and-us-launch#.UQBHR9GgtLs.twitter
"We believe that the company may be issuing a press release tonight or tomorrow to announce the US availability of Vascepa."
"Within the next few days, possibly as soon as this evening, AMRN will issue a press release announcing US availability of Vascepa"
"Depending on how the initial script numbers come in, AMRN stock will either begin a gradual recovery to the $10 - $12 range or drift lower to the $7 - $5 range over the next two months."
como curiosidad, una grande MERCK con problemas de un medicamento, TREDAPTIVE, lo retiran del mercado
http://www.benzinga.com/pressreleases/13/01/b3234967/merck-provides-update-on-next-steps-for-tredaptive-extended-release-nia